NCT02871440View on ClinicalTrials.gov

A Two Comparator, Controlled Phase 3 Study in Patients With and Without Evaporative Dry Eye

PHASE3CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

September 19, 2016

Primary Completion Date

September 18, 2017

Study Completion Date

September 18, 2017

Conditions
Dry Eye Syndromes
Interventions
DRUG

Omega 3

DRUG

Optive Advanced

DRUG

Optive

Sponsors

Collaborators (1)

Allergan
All Listed Sponsors
collaborator

Allergan

INDUSTRY

lead

The University of New South Wales

OTHER